Development of Blood-Based Alzheimer’s Prognostic Propels Diadem to Finalist Status for Both the Gaetano Marzotto Company Prize and 2030 Social Impact Special Prize
Milan, ITALY – November 16, 2020
pool of 600 applicants. The companies were analyzed by experts representing relevant public, private, financial, technological and specialist...
Diadem Names Clinical Diagnostics Industry Veteran Paul Kinnon as CEO
Milan, ITALY – October 19, 2020
Diadem srl, a company developing the first blood-based test for the prediction of early onset Alzheimer’s disease, today announced that Paul Kinnon has been named...
Italiano | English